
Eli Lilly U.S. Manufacturing Investment to Exceed $50 Billion
Eli Lilly and Company announced plans to bolster its domestic medicine production across therapeutic areas by building four new pharmaceutical manufacturing sites in the United States.
Eli Lilly and Company announced plans to bolster its domestic medicine production across therapeutic areas by building four new pharmaceutical manufacturing sites in the United States.